That's true, but it still has good, relevant info that can be insightful for someone starting their DD. I'm sure the serious investor would browse through and read this article with a grain of salt, using it only to ask questions in further investigating the company. Besdies, hopefully we will have some pretty awesome new sticky coming with a big trial data update eventually